Five life sciences research projects nearing market stage land MN-REACH funding.
Health Care + Med Tech
Patent application filed on antibody used for individualized cancer treatments.
Blue Cross surveys understanding of health plans.
Minnesota records an A and a B on latest state telemedicine report cards.
The Mayo Clinic was the state’s top earning health institution, taking in nearly $10.8 million from medical device makers and others in the field.
The medtech company’s sales rose 11 percent year-over-year during the three-month period.
The unit could sell for as much as $5 billion, according to people familiar with the matter.
Howard Root, CEO of the medtech company, said the accusations have “no merit and we’ll prove it.”
The Brothers Snyder laud hometown’s buzzing bio-business startup scene.
Medtech firm went public in 2015.
Minnesotans pay $32 less than the national average for single coverage.
It would allow therapies to bypass ‘blood-brain barrier’ to treat neuro conditions.
The deal makes more changes than Dayton originally proposed, but is significantly pared down from a previous GOP-backed bill.
Meanwhile, medtech competitors Boston Scientific and St. Jude Medical are awaiting FDA approval for their leadless pacemaker models.
Startup Medicool targets irregular heartbeat with $250K NSF seed funding.
Reports foreshadow rise in number of people struggling to pay off health bills.
Developers to add second health care project to CityPlace.
It’s the latest fundraising effort from a company that has struggled to turn a profit.